Search - tctmd.com

Displaying 81 - 100 of 588

Sort: Relevancy | Date

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Conference News SCCT 2024

AI Expected to Augment Workload, Not Put Cardiac Imagers Out of Work

Todd Neale

July 23, 2024

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Caitlin E. Cox

July 10, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News SCAI 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

L.A. McKeown

May 10, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ACC 2024

Even When Nearby, Public AEDs Get Little Use in OHCA

L.A. McKeown

March 28, 2024

News Conference News CRT 2024

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

L.A. McKeown

March 19, 2024

Advertisement

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

TCTMD’s Top 10 Most Popular Stories for July 2024

AI Expected to Augment Workload, Not Put Cardiac Imagers Out of Work

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

July 2024 Dispatch for the CV Team

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

June 2024 Dispatch for the CV Team

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

May 2024 Dispatch for the CV Team

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

April 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Even When Nearby, Public AEDs Get Little Use in OHCA

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content